STZ given intravenously or intraperitoneally to laboratory mice in multiple sub-diabetogenic doses, induces pronounced pancreatic insulitis with eventual destruction of insulinsecreting beta cells and diabetes mellitus.
STZ given intravenously or intraperitoneally to laboratory mice inmultiple sub-diabetogenic doses, induces pronouncedpancreatic insulitis with eventual destruction of insulinsecretingbeta cells and diabetes mellitus.